| Business Type | Manufacturer, Exporter, Supplier, Retailer, Trader, Distributor |
| Country of Origin | india |
| Brand Name | Mounjaro 2.5mg KwikPen |
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| Click to view more | |
Product Details
Mounjaro 2.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.
Mounjaro 2.5mg KwikPen is administered once weekly subcutaneously in the abdomen, thigh, or upper arm. To maximize its benefits, maintain a consistent injection schedule and complement treatment with a healthy diet and regular exercise. Follow your doctor’s instructions carefully, including any dose adjustments, and store the medication properly in the refrigerator. Common side effects of Mounjaro 2.5mg KwikPen include nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are typically mild and improve over time. If they become severe or persistent, consult a doctor.
Raise your Query
Hi! Simply click below and type your query.
Our experts will reply you very soon.